Aligos Therapeutics Inc (ALGS): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 24.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 56,286 US Dollar | 2 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 5.388.223 | 9,93 | 1,83 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Aligos Therapeutics Inc
Mitarbeiter 82
Handelsplatz NASDAQ
Ticker Symbol ALGS
IPO Datum 2020-10-16
Adresse One Corporate Drive, South San Francisco, CA, United States, 94080
Webseite https://www.aligos.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Lawrence M. Blatt MBA, Ph.D. | CEO, President & Chairman of the Board |
| 2 | Ms. Lesley Ann Calhoun CPA | Executive VP, CFO & COO |
| 3 | Dr. Julian A. Symons DPHIL | Executive VP & Chief Scientific Officer |
| 4 | Mr. Nikhil Aneja | Principal Accounting Officer |
| 5 | Ms. Laura Kavanaugh | VP & Head of Legal |
| 6 | Ms. Kristina Engeseth M.B.A. | Senior VP and Head of People & Culture |
| 7 | Dr. Sushmita M. Chanda DABT, Ph.D. | Executive Vice President & Chief Development Officer |
| 8 | Dr. David B. Smith Ph.D. | Executive VP & Head of Chemical Operations |
| 9 | Dr. Tse-I Lin Ph.D. | Senior VP of Early Compound Development & Belgian Site Head |
| 10 | Dr. Kieron Wesson Ph.D. | Vice President & Head of Chemistry Manufacturing Controls |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Deep Track Capital, LP | 7,18% | 1,81 Mio. USD |
| 2 | Alyeska Investment Group, L.P. | 6,66% | 1,68 Mio. USD |
| 3 | Sio Capital Management, LLC | 5,29% | 1,34 Mio. USD |
| 4 | Marshall Wace Asset Management Ltd | 4,32% | 1,09 Mio. USD |
| 5 | Bank of America Corp | 3,71% | 0,94 Mio. USD |
| 6 | Vanguard Group Inc | 3,24% | 0,82 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 2,88% | 0,73 Mio. USD |
| 8 | Woodline Partners LP | 2,87% | 0,72 Mio. USD |
| 9 | SummitTX Capital, L.P | 2,40% | 0,61 Mio. USD |
| 10 | Renaissance Technologies Corp | 1,62% | 0,41 Mio. USD |
| 11 | Baker Bros Advisors LP | 1,34% | 0,34 Mio. USD |
| 12 | Hillhouse Capital Advisors, Ltd. | 1,23% | 0,31 Mio. USD |
| 13 | Citadel Advisors Llc | 0,88% | 0,22 Mio. USD |
| 14 | LPL Financial Corp | 0,83% | 0,21 Mio. USD |
| 15 | Geode Capital Management, LLC | 0,81% | 0,20 Mio. USD |
| 16 | UBS Group AG | 0,60% | 0,15 Mio. USD |
| 17 | Vanguard Fiduciary Trust Co | 0,46% | 0,12 Mio. USD |
| 18 | Two Sigma Investments LLC | 0,37% | 0,09 Mio. USD |
| 19 | Verition Fund Managegment, LLC | 0,31% | 0,08 Mio. USD |
| 20 | XTX Topco Ltd | 0,23% | 0,06 Mio. USD |